Posts
January 22 2024
RedHill Biopharma Ltd. announced the closing of its Registered Direct offering in the amount of $8,000,000. EG&S acted as counsel to the Placement Agent.
January 21 2024
RedHill Biopharma Ltd. announced the closing of its Registered Direct offering in the amount of $8,000,000. EG&S acted as counsel to the Placement Agent.
January 18 2024
TransCode Therapeutics, Inc. announced the closing of its Public Offering in the amount of $7,250,000. EG&S acted as counsel to the Placement Agent.
January 17 2024
Jennifer Calamia, an associate of the Firm, wrote an article for Total Food Service titled: “Online Recruitment of Employees: Navigating the Novel Legal Challenges“.
Click here to read the article.
January 15 2024
PolyPid Ltd. announced the closing of its Private Placement in the amount of $16,200,000. EG&S acted as counsel to the Placement Agent.
January 15 2024
TransCode Therapeutics, Inc. announced the closing of its Public Offering in the amount of $7,250,000. EG&S acted as counsel to the Placement Agent.
January 13 2024
SeaStar Medical Holding Corporation announced the closing of its Registered Direct offering in the amount of $9,000,000. EG&S acted as counsel to the Placement Agent.
January 10 2024
Client Alert: U.S. Department of Labor Announces Final Rule Regarding Classification of Independent Contractors
Yesterday, the U.S. Department of Labor (“DOL”) unveiled the details of a long-awaited final rule clarifying its guidance on determining whether a worker should be classified as an “employee” or “independent contractor” under the Fair Labor Standards Act (“FLSA”) (the “Final Rule”). The Final Rule takes effect March 11, 2024.
Click here to read the alert.